Introduction C hronic hepatitis B virus (HBV) infection may progress into severe liver disease, such as liver cirrhosis and liver cancer. 1 Worldwide, the prevalence of chronic HBV (measured by testing hepatitis B surface antigen (HBsAg) in blood) varies widely with the highest prevalence in countries of the African-and South-East Asian region. 2 In the Netherlands, 0.2% of the general population is HBsAg positive 3 and each year an estimated 200 individuals die of sequelae of chronic HBV infection. 4 Among Dutch first generation immigrants originating from intermediate-or highendemic countries, the HBsAg prevalence was estimated as high as 3.77%. 3, 5, 6 With 385 761 individuals (2016), Moroccans represent together with Turks (397 471 individuals) the largest immigrant groups in the Netherlands. Of the total Dutch population, 2.3% is Moroccan and 2.3% is Turkish. 7 There are 168 336 first generation MoroccanDutch of which about half live in urban areas: Amsterdam (21%), Rotterdam (12%), Utrecht (8%) and The Hague (8%). 8 In Morocco, the prevalence of HBsAg is 1.81%. 9 Two small studies showed lower chronic HBV prevalences among Moroccan-Dutch (0.4 and 0%). 10, 11 However, a meta-analysis found similar chronic HBV prevalence rates in migrants compared with the prevalence of chronic HBV in their countries of origin. 12 This suggests that the prevalence among first generation Moroccan-Dutch may be similar to its prevalence in Morocco.
In November 2016, the Dutch Health Council recommended blood testing of all first generation immigrants originating from countries with intermediate or high HBV endemicity to detect chronically infected individuals and refer them for monitoring or immediate treatment. Identification of infected individuals also allows measures to prevent further HBV transmission. The Council proposed two implementation strategies: (i) individual case finding by general practitioners (GPs), and (ii) screening programmes in cities or regions with large immigrant numbers. 13 In 1989, the Netherlands introduced antenatal HBV screening for pregnant women to prevent mother-to-child transmission.
14 This means that up to now, no national HBV screening programme, specifically directed at first generation immigrants, was in place.
Because of the recent recommendation, there is no information (yet) regarding the numbers of HBV screening participation among first generation Moroccan-Dutch. What we do know, is that other health-related screening programmes reported lower attendance rates among Moroccan-Dutch compared with indigenous populations. [15] [16] [17] [18] [19] Visser et al. 19 reported a participation rate in breast cancer screening (1995-2001) of 37% for Moroccan women, significantly lower than the overall attendance of 76%. In 2007-08, the overall attendance at breast cancer screening increased to 83%, but (again) remained significantly lower for Moroccan women (54%). 18 During the cervical cancer screening (1998) (1999) (2000) (2001) , the overall attendance was 55.7%; again less Moroccan women participated (35.9%). 17 Therefore, eliminating barriers for participation in HBV screening is demanded and requires identification of determinants of screening behaviour among Moroccan-Dutch. 20 Earlier qualitative studies focussing on other preventive programmes for Moroccan-Dutch reported lack of awareness and knowledge, organizational issues (e.g. too busy), socio-cultural aspects (e.g. low level of education and fear of social isolation), perceived susceptibility and benefits and barriers (e.g. fear of the test result) as important determinants for participation in preventive programmes. 15, [21] [22] [23] [24] Although extensive research was conducted on determinants to participate in HBV screening among Turkish-Dutch, 25 no study examined these determinants among Moroccan-Dutch. Prior to implementing screening programmes as proposed by the Dutch Health Council, our aim was to identify determinants associated with HBV screening participation among first generation Moroccan-Dutch.
Methods

Sampling
We used purposive snowball sampling, since it may allow us to reach and study migrants (a hard-to-reach population). As a disadvantage, it may result in selection bias, as participants' social networks are not random. To limit this form of bias, we used various sources to approach possible study participants, namely community organizations (community and day care centres, mosques, interest groups and civil support foundations) located in various cities in the Netherlands (i.e. mainly Amsterdam, Rotterdam, Utrecht and The Hague), and assured maximum variation in our sample by including male and female participants from different places and of different ages with various levels of education and Dutch language proficiency.
Although first generation migrants (FGM) are the targeted group for screening, we also interviewed second generation migrants (SGM), since they frequently act as brokers for their (grand-)parents in contacts with the Dutch healthcare system. 26 FGM were defined as individuals born in Morocco and having at least one parent born in Morocco. SGM were defined as individuals born in the Netherlands and having at least one parent born in Morocco. 27 Of all study participants, we did not know their HBV screening status prior to interviewing, as we wanted to gather information, independently of their status. New study participants were recruited until data saturation was reached (i.e. no new information was found during the last interviews).
Prior to each interview, participants were verbally informed about the study and asked to sign an informed consent form. Participants received a small (non-monetary) token of appreciation. The medical ethical committee of the UMC Utrecht approved this study [16- 
Semi-structured interviews
Semi-structured interviews were held by a native Dutch-Berber speaking female researcher in Dutch, Berber or a combination of both, and lasted $1 h.
We developed a topic list consisting of questions about potential determinants of the intention to have a HBV blood test. This list was based on a compilation of the Health Belief Model (HBM), the Theory of Planned Behaviour (TPB), the Betancourt's Model of Culture and Behaviour and literature on determinants for (non-) participating to other screening programmes. 15, [21] [22] [23] [24] [25] Van der Veen et al. 28 proposed this compilation as a conceptual model for her study among Turkish-Dutch regarding HBV screening participation (see Supplementary figure S1 ).
Interviews started with broad questions regarding knowledge and awareness of HBV. If participants were unfamiliar with the topic, concise verbal information about HBV, transmission and testing was given. As sexual contact and drug use are often seen as taboo, we did not actively inform participants about these transmission routes. We informed participants about the main transmission routes among Moroccan migrants, which are perinatal transmission and blood contact between family members. 5 However, if interviewees mentioned sexual contact and/or drug use by themselves, we also discussed these topics. Detailed background information was made available in Dutch through our project website (www.rivm.nl/ Onderwerpen/H/Hepatitis_B/MARAZ_onderzoek_hepatitis_B).
Subsequently, we asked questions concerning potential determinants of health behaviour, including topics such as shame and stigma.
At the end of each interview, socio-demographic data of the participants were recorded. Participants were also asked to score their Dutch language proficiency as 1 (poor), 2 (average) or 3 (excellent).
Interviews were audio recorded. During one interview, the tape recorder broke down at the start, and one interviewee refused to be recorded. In these two cases, notes were taken and summarized at the end of the interview.
Data analysis
Recordings were transcribed ad verbatim and thematically analysed through coded transcripts by NH using ATLAS.ti version 7.5.6. A random 30% of all participants was double coded by MLS, MvdM and JvS, and findings were subsequently discussed to reach consensus about their meaning. Berber interviews were directly translated into Dutch transcripts.
Results
Study participants
We included 9 first (FGM) and 10 second generation MoroccanDutch migrants (SGM) (see Supplementary table S1). The majority was female (63%), and all participants were Muslim. FGM had a mean age of 47 years compared with 26 years for SGM. Four FGM (57% of all FGM) reported to have completed a medium level of education or higher. Of the SGM, 70% had a medium or higher level of education. FGM and SGM both reported a median Dutch proficiency score of 3.
Thematic analysis
We extracted the following themes that may influence the intention to have a HBV blood test: (i) awareness and knowledge, (ii) cultural aspects and religion, (iii) practical issues, (iv) fear about the test result, (v) perceived benefits, (vi) perceived social norm and (vii) perceived susceptibility to and severity of disease. 
Awareness and knowledge
Cultural aspects and religion
Cultural aspects Most participants (n = 15) expressed that, in general, diseases are taboo in the Moroccan culture. Some SGM participants (n = 3) mentioned high health care utilization of their (grand-)parents (FGM) as facilitator, and one SGM participant mentioned fear of developing cancer as barrier for taking the HBV test (see box 1).
Religion Some participants introduced Islam as a topic. According to two participants, people's way to practice their religion may limit their testing behaviour. On the contrary, others mentioned that it could also stimulate people to test (see box 1).
Shame and stigma
Association of hepatitis B with sexuality We explored this theme with participants who knew that HBV can be transmitted sexually. A few female participants (n = 2) mentioned a difference between men and women regarding the sensitivity among sexuality and indicated the association of hepatitis B with sexuality as barrier (see box 2).
Association of hepatitis B with drugs Although hepatitis B was more often associated with sexuality, two female participants mentioned the association with drugs as barrier (see box 2).
Disclosure of HBV status Some participants (n = 3) thought people would be afraid about others' disapproving opinion if they would get to know their HBV status. If someone would be tested positive for HBV, they would only disclose this to their partner and/or a limited number of family members (see box 2).
Practical issues
The majority did not express any practical issues that may limit them to have a HBV test. However, a few participants (n = 2) could imagine practical issues that may impede HBV testing, such as an insufficient Dutch language proficiency. Additionally, the majority (n = 10) mentioned the costs of the test as a possible obstacle (see box 3).
Fear about the test result
Fear about the test result was frequently mentioned as a serious barrier (see box 3).
Perceived benefits
Most participants (n = 13) had a positive attitude towards the HBV test and expressed that it will potentially benefit their health, or of their (grand-)parents. The saying 'A stitch in time saves nine' (meaning: 'Prevention is better than cure') was often mentioned. Preventing potential HBV transmission to others was seen as an additional benefit (see box 4).
Perceived social norm
As for the social norm regarding HBV, many participants talked about others (including family and friends) who may avoid the ones with HBV, because of their fear to become infected as well. This social norm regarding HBV may influence the testing behaviour of FGM negatively, as people also mentioned social pressure or control. Other FGM, and to a lesser extent SGM, acknowledged the existence of social norms, but did not want to interact in this social environment. These female participants would rather consult their partner or GP to decide whether they should take the test (see box 4).
Perceived susceptibility to and severity of disease
A low-risk perception seemed to be an important determinant of male SGM participants for not recommending the test to their (grand-)parents. This is in contrast of what female SGM participants expressed. They addressed the flawed risk perception of others while stating that this indifference should be fought (see box 4).
Discussion
This is the first qualitative study identifying facilitators and barriers for participating in chronic HBV screening among FGM and SGM Moroccan-Dutch. Most participants had little knowledge about HBV, but had a positive attitude towards testing. Facilitators were perceived susceptibility to (in women) and severity of disease, positive attitude regarding prevention, the wish to know their HBV status, and to prevent potential HBV transmission to others. Cultural facilitators included fear of developing cancer and high health care utilization. A religious facilitator was the responsibility for one's health and that of others. Barriers included lack of awareness and knowledge, practical issues, not having symptoms, negative attitude regarding prevention, fear about the test result and low-risk perception (in men). An important cultural barrier was shame and stigma as (i) diseases are taboo, (ii) hepatitis B may be associated with sexual contact and drug use and (iii) disclosure of HBV status. An important religious barrier was fatalism, which is an attitude emphasizing the subjugation of all events to fate. Some factors, such as perceived social norm or support, religion and knowledge, seemed to act as facilitator and barrier, as seen in our proposed mechanisms (see Supplementary figures S2-S4). The label 'being different' may act as barrier, while social support may stimulate people to have themselves tested. Religion can act as facilitator if one takes responsibility of one's own health and prevents HBV transmission in the light of the Islam, but as barrier if people interpret their health as predestined and not as something they can control (i.e. fatalism).
Overall, our findings are in line with previous studies that focused on preventive behaviour of Moroccan-Dutch, 15, [21] [22] [23] [24] e.g. lack of Dutch language proficiency, 15, 21, 23, 24 costs, 23 and gender differences with respect to HBV risk perception. 29 However, our study identified specific facilitators and barriers, such as the association of HBV with sexual contact and drugs.
Despite several differences between Moroccan-Dutch and Turkish-Dutch, such as culture, 30 Dutch language proficiency 7 and screening participation, [15] [16] [17] [18] [19] it is relevant to compare these groups because of their comparable migration status, religion and socioeconomic status. Regarding HBV specific determinants, Van der Veen et al. 31 found in Turkish-Dutch (religious) responsibility for one's health, reputation and social support in being tested for HBV as facilitators. This is similar to our findings in Moroccan-Dutch. Both in Turkish-and Moroccan-Dutch, barriers were found to be the association of HBV screening with sexual contact and fatalism. In contrast, Moroccan-Dutch also mentioned drug use as an undesirable association with HBV.
In comparison to Van der Veen et al., 31 we did not only focus on socio-cultural determinants and, therefore, found determinants that are guided by the HBM and the TPB. Turkish-Dutch mentioned perceived low efficacy of Dutch health care services as barrier and perceived obligation when being invited for screening as facilitator, 31 which were not found in our study. This may be related to the low perceived quality of the Moroccan health care compared with the Dutch, while Turkish-Dutch perceive a higher quality of health care in Turkey compared with the Netherlands. Also, as we identified 'not having symptoms' as barrier, Moroccans may feel less obligated to participate in screening compared with Turkish-Dutch.
Strengths and limitations
An important strength of our study is the inclusion of SGM, who were generally more assertive and outspoken. This led to more information on topics, such as sexual contact, drug use and fatalism.
Additionally, since SGM frequently act as brokers for their (grand-)parents in contacts with the Dutch healthcare system, 26 they represent an important group to consider in programmes oriented at screening first generation Moroccan-Dutch. Second, to ensure reliability, data were double coded by a second researcher. Third, we mainly targeted cities with a high density of first generation Moroccan-Dutch, for which the Dutch Health Council also proposed HBV screening programmes.
However, there were also limitations in this study. First, we did not specifically ask participants whether they were screened for HBV. It is possible that HBV screening status influenced our study participants' opinions and the discussion at large. Second, participants did not have the opportunity to review their transcripts. This may have led to reduced internal validity. As Berber is only a spoken language, transcripts were translated and written in Dutch, which may not be easily read by most FGM participants. Third, selection bias might have occurred, as most participants were women and highly educated. The interviewer was a female Moroccan-Dutch researcher, which may have discouraged Moroccan-Dutch men to participate due to their religiousness and cultural norms. These factors may additionally have restricted men, but possibly also women, in what they expressed during the interviews. Unfortunately, it was not feasible in our time frame and budget to include a male Moroccan-Dutch researcher. Moreover, although we did not explore gender differences explicitly, our findings suggested several, as male SGM participants expressed low HBV risk perception as barrier, female participants mentioned the association of HBV with sexuality and drugs and female participants expressed a gender difference regarding sensitivity among sexuality. These differences are only suggestive because of the qualitative nature of this study. These findings seem to imply the importance of tailored communication strategies based on gender, but further research on gender differences is needed. Furthermore, our finding of determinants acting as facilitator and barrier is challenging for communication strategies. This dual effect shows the intrinsic limitation of choosing and labelling determinants of human behaviour. Determinants are not existing entities in the real world, but are chosen terms, used as metaphors trying to understand health behaviour. Peters and Crutzen argue not to build theories using determinants, but to establish a 'pragmatic nihilism' perspective, for which, it is essential to define theories and to develop guidelines to operationalize such determinants. 32 For developing communication strategies for screening participation, this study provided sufficient Box 4 Quotes belonging to 'Perceived benefits', 'Perceived social norm' and 'Perceived susceptibility to and severity of disease' information and guidance. For future studies, it would be interesting to follow the approach of 'pragmatic nihilism', and recreate and operationalize determinants. Finally, although this study provided insight into determinants of HBV testing behaviour in MoroccanDutch, we recommend confirming these results quantitatively in a large representative sample of this population.
Implications and future research
As the majority of participants lacked awareness and knowledge (i.e. health literacy 33 ) regarding HBV, an educational campaign is a cornerstone for participation and should by all means be introduced in Amsterdam, Rotterdam, Utrecht and The Hague. This campaign can be tailored to the needs of Moroccan-Dutch using the obtained knowledge. Moreover, as flawed risk perceptions are present, clear and visual information on the risk of developing chronic HBV and liver cancer should be provided to aid informed decision-making among Moroccan-Dutch.
Conclusion
This study identified important facilitators and barriers, which require careful consideration when designing and implementing communication strategies. Specific and accurate knowledge provision is important, but should be accompanied by strategies to address shame and stigma. Islamic religious leaders within the MoroccanDutch community should, therefore, be informed about hepatitis B and risk (i) to bring information across, (ii) to decrease elements of shame and stigma, leading to more acceptance of HBV screening.
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